Bayer's Laura Pierce and Chris Seaton give insight into Bio Partnerships and Pharma's Future in Exclusive BioNetwork Interviews

LAGUNA NIGUEL, CA (September 27, 2010) - BioNetwork 2010, a top tier biotech/pharma industry partnering conference, interviewed two top executives from Bayer Healthcare Pharmaceuticals, who stressed the importance of effective partnerships and innovations for the future of industry. According to an interview with Laura Pierce, Vice President, Alliance Management, a large portion of revenue comes from strategic partnerships which must be approached with careful attention to good and bad possible outcomes. In a second interview, Chris Seaton, Senior Vice President, Global Transactions, gives his outlook on the future of pharma, predicting a period of great innovation and a return to the root purpose of pharma which is to improve people's lives and health.

Both Pierce and Seaton will speak at BioNetwork 2010, which takes place October 25 to 27, 2010 at the Ritz Carlton, Laguna Niguel. BioNetwork offers a unique experience by providing the latest trends and best practices in deal-making while providing an intimate atmosphere to meaningfully connect and meet with participants from Big Pharma and biotech industries.


“> Listen to our interview with Laura Pierce.
Listen to our interview with Chris Seaton.

Along with Bayer Healthcare Pharmaceuticals, other companies presenting include Bristol Myers Squibb, Pfizer, Eli Lilly, Merck, GlaxoSmithKline, Allergan, Johnson & Johnson and another 40 speakers sharing specific co-promotion case studies and best practices in partnering, deal-making and alliance management.

In addition to the exciting discussions, BioNetwork is also introducing a new opportunity for small biotechs to get in front of potential partners and investors through "The Perfect Pitch: Biotech Investment Challenge." Hear insightful feedback from a select panel of judges representing Big Pharma and the investment community on how you can be most effective in delivering your company presentations to your potential investors.

For more information about the BioNetwork conference, contact Leanne Arcinue, Divisional Director at Worldwide Business Research via email llarcinue@wbresearch.com.

About Worldwide Business Research
WBR is the world's biggest large-scale conference company and part of the PLS group, one of the world's leading providers of strategic business intelligence with 16 offices worldwide. Our conference divisions consistently out-perform their industry sector competitors on the quality of the events we produce and the relationships we nurture with both delegates and sponsors. Every year, more than10,000 senior executives from Fortune 1000 companies attend more than 100 annual conferences – a true "Who's Who" of today's corporate world. From automotive events in Bucharest to logistics conferences in Arizona and finance summits in Hong Kong, WBR is dedicated to exceeding the needs of its customers around the world.